Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis
Status:
Terminated
Trial end date:
2020-05-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficiency of topical gancyclovir 0.15% in the
treatment of herpes zoster keratitis. Half the patients will receive the study drug while the
other half of the patients will receive the placebo